Compliments of Grunfeld, Desiderio, Lebowitz, Silverman & Klestadt LLP
The Office of the United States Trade Representative (“USTR”) announced that it is temporarily extending the China 301 tariff exclusions on 99 medical care products through November 14, 2021.
On December 29, 2020, in response to the evolving COVID-19 situation, the USTR had announced that it was extending expiring China 301 tariff exclusions on certain medical care products and designating certain additional such exclusions for the period January 1, 2021, through March 31, 2021. Such exclusions (99 in total) were subsequently extended through September 30, 2021.
In an August 27, 2021 notice, the USTR sought comments from the public as to whether each of these exclusions should be further extended in light of COVID-19 developments. The due date for comments was September 27, 2021. In order to provide ample time for the review of comments, the USTR is extending these exclusions, on an interim basis, until November 14, 2021.
Further background on this action (including a link to the specific products impacted) can be accessed at: https://www.gdlsk.com/ustr-extends-certain-china-301-exclusions-and-designates-additional-exclusions-for-the-period-january-1-march-31-2021/
The exclusions (click here for full list) are available for any product that meets the specified HTSUS numbers and product descriptions, regardless of whether the importer filed an exclusion request.
Please contact your Western Overseas representative if you have questions.
